OPNT: Increasing Royalties from NARCAN® Nasal Spray… - Zacks Small Cap Research
2021-03-30 • Google News
Opiant Pharmaceuticals Inc (OPNT)
US$ 11.64-8.27%
Price Chart
Key Statistics
Market Cap
$ 108.8M
P/E Ratio
0.00
Revenue (TTM)
$ 22.34M
Volume
9.84K
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
0.83
Technicals
50-Day MA
20.503
200-Day MA
14.7938
52 Week High
N/A
52 Week Low
N/A
About OPNT
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.
Employees
37
Headquarters
Santa Monica, CA
CEO
Dr. Roger Crystal M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg